Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)
by Fasching, Peter Andreas (Author)
, Link, T. (Author)
, Hauke, J. (Author)
, Seither, F. (Author)
, Jackisch, C. (Author)
, Klare, P. (Author)
, Schmatloch, S. (Author)
, Hanusch, C. (Author)
, Huober, J. (Author)
, Stefek, A. (Author)
, Seiler, S. (Author)
, Schmitt, W. D. (Author)
, Uleer, C. (Author)
, Doering, G. (Author)
, Rhiem, K. (Author)
, Schneeweiss, Andreas (Author)
, Engels, K. (Author)
, Denkert, C. (Author)
, Schmutzler, R. K. (Author)
, Hahnen, E. (Author)
, Untch, M. (Author)
, Burchardi, N. (Author)
, Blohmer, J. -U. (Author)
, Loibl, S. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource